Initiation of glucagon like peptide-1 agonists may increase risk of gallbladder or bile duct disease and cholecystectomy; no increased risk associated with DPP-4 inhibitor therapy.
Read More »Pioglitazone First Medication to Prevent Diabetes Progression Including Cardiovascular Events
Study could not evaluate drug's long-term effects on diabetes prevention, length of effects
Read More »Expanding the Role of Canagliflozin in the Elderly
What benefits can medication provide in elderly patients with uncontrolled type 2?
Read More »A Lot to Learn from Your Patients
I am a diabetes educator and certified foot care nurse. Through the years, I’ve learned that most topics we teach people who have diabetes are really topics every person should know about. I teach patients how to care for their feet, how to prevent foot problems, and how to treat them if they should have problems.
Read More »The Impact of Glycated Albumin in Diabetes Management and Diabetic Nephropathy
Can glycated albumin provide better positive predictive value than A1c in incidence of diabetic nephropathy?
Read More »The Role of Buprenorphine in Diabetic Neuropathic Pain
Study finds improvement in pain relief and sleep patterns
Read More »Cardiovascular Mortality of Diabetes Medications
What should be the proper treatment selection for patients with type 2 diabetes?
Read More »Metformin in Type 1 Patients Slows Development of Heart Disease
Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.
Read More »Fenofibrate Therapy in Diabetic Retinopathy
Studies suggest fenofibrate can prevent microvascular changes, decrease need for surgery.
Read More »Chronic Kidney Disease and the Incidence of Diabetes
Tighter glucose and blood pressure control found to decrease incidence.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.